Our experiments in HCC cells validated that TGF-β1 could increase Siglec-15 promoter activity through upregulation of ETS-1 and ETS-2 and consequently activate mRNA transcription and protein expression of Siglec-15. This evidence concerns the gene TGFB1 and hepatocellular carcinoma.